Increased Uptake of Guideline-Recommended Oral Antiplatelet Therapy: Insights from the Canadian Acute Coronary Syndrome Reflective

Canadian Journal of Cardiology

Volumn 30, Issue 12, 2014, Pages 1725-1731

  Gandhi, Sumeet ^a,j   Zile, Brigita ^a,b   Tan, Mary K ^b   Saranu, Jhansi ^b   Bucci, Claudia ^c   Robertson, Patrick ^d   Quantz, Mackenzie A ^e   Letovsky, Eric ^f   Tanguay, Jean Francois ^g   Dery, Jean Pierre ^h   Fitchett, David ^a   Madan, Mina ^c   Cantor, Warren J ^f   Heffernan, Michael ⁱ   Natarajan, Madhu K ^j   Wong, Graham C ^k   Welsh, Robert C ^l   Goodman, Shaun G ^a,b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b CANADIAN HEART RESEARCH CENTRE   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d ROYAL UNIVERSITY HOSPITAL   (Canada)

^e LONDON HEALTH SCIENCES CENTRE   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g MONTREAL HEART INSTITUTE   (Canada)

^h LAVAL UNIVERSITY   (Canada)

ⁱ Oakville Hospital   (Canada)

^j MCMASTER UNIVERSITY   (Canada)

^k UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^l UNIVERSITY OF ALBERTA   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE RECEPTOR INHIBITOR; ANTITHROMBOCYTIC AGENT; APIXABAN; CLOPIDOGREL; DABIGATRAN; PRASUGREL; RIVAROXABAN; TICAGRELOR; UNCLASSIFIED DRUG; WARFARIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CANADIAN; CLINICAL PRACTICE; DRUG USE; FEMALE; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; UNSTABLE ANGINA PECTORIS; CANADA; CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION; ELECTROCARDIOGRAPHY; FOLLOW UP; MULTICENTER STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REGISTER; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; AGED; CANADA; DRUG ADMINISTRATION SCHEDULE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GUIDELINE ADHERENCE; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; REGISTRIES; TREATMENT OUTCOME;

EID: 84919771761     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2014.09.011     Document Type: Article

References (11)

1. Tanguay J.F., Bell A.D., Ackman M.L., et al. Focused 2012 Update of the Canadian Cardiovascular Society Guidelines for the Use of Antiplatelet Therapy. Can J Cardiol 2013, 29:1134-1145.
2. Mehta S.R., Bassand J.P., Chrolavicius S., et al. Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. NEngl J Med 2010, 363:930-942.
3. Wiviott S.D., Braunwald E., McCabe C.H., et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007, 357(20):2001-2015.
4. Wallentin L., Becker R.C., Budaj A., et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. NEngl J Med 2009, 361:1045-1057.
5. Rao R.V., Goodman S.G., Yan R.T., et al. Temporal trends and patterns of early clopidogrel use across the spectrum of acute coronary syndromes. Am Heart J 2009, 157:642-650.e1.
6. Goodman S.G., Huang W., Yan A.T., et al. The expanded Global Registry of Acute Coronary Events: baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes. Am Heart J 2009, 158:193-201.e1-5.
7. Banihashemi B., Goodman S.G., Yan R.T., et al. Underutilization of clopidogrel and glycoprotein IIb/IIIa inhibitors in non-ST-elevation acute coronary syndrome patients: the Canadian global registry of acute coronary events (GRACE) experience. Am Heart J 2009, 158:917-924.
8. Yan A.T., Yan R.T., Tan M., et al. Management patterns in relation to risk stratification among patients with non-ST elevation acute coronary syndromes. Arch Intern Med 2007, 167:1009-1016.
9. McAlister F.A., Oreopoulos A., Norris C.M., et al. Exploring the treatment-risk paradox in coronary disease. Arch Intern Med 2007, 167:1019-1025.
10. Patti G., Colonna G., Pasceri V., et al. Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study. Circulation 2005, 111:2099-2106.
11. Mehta S.R., Tanguay J.F., Eikelboom J.W., et al. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial. Lancet 2010, 376:1233-1243.